Bitcoin prediction markets still see $100,000 hitting by New Year despite mounting BTC price selling pressure.

Shubham Pant, MD, MBBS, discussed the use of zanidatamab and the HERIZON-BTC-01 trial in HER2-positive biliary tract cancer ...

Analyzing the risks and benefits of investing in MSTY and MSTR in a volatile market influenced by BTC/USD movements.

Bitcoin flirts with $100K after SEC Chair Gary Gensler announces resignation. Anthony Pompliano calls the timing "poetic" for ...

Layer-1 blockchain Aptos (APT) has announced a plan to integrate fintech giant Stripe's payment services and the stablecoin ...

If the Senate confirms Bessent, the next person whose signature is on the front of paper U.S. currency will be a fan of ...

Citron said it had hedged its perspective with a short position against MicroStrategy, even though it maintained a positive ...

Bitcoin (BTC) has only a few hundred BTC in sell walls to conquer. At $100K, only 1,000 BTC are available, potentially ...

Bitcoin is nearing $100,000, thanks in part to Donald Trump's re-election. Crypto experts think it's poised to continue, but ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Bitcoin (BTC-USD) is set to rise 8.3% on a weekly basis, as the cryptocurrency continues to see a meteoric rise after Donald ...

The Bitcoin price closed on $100K, but MSTR stock plunged and the Crypto All-Stars presale blasted past $5 million.